Core Viewpoint - The Varonis Systems, Inc. is facing a class action lawsuit due to allegations of misleading investors regarding its revenue outlook and growth potential, leading to significant stock price declines following disappointing financial results [3][4]. Group 1: Class Action Details - The class action lawsuit is titled Molchanov v. Varonis Systems, Inc., and it involves purchasers of Varonis common stock from February 4, 2025, to October 28, 2025 [1]. - Investors have until March 9, 2026, to apply for lead plaintiff status in the lawsuit [1]. - The lawsuit alleges that Varonis and its executives violated the Securities Exchange Act of 1934 [1]. Group 2: Allegations Against Varonis - The lawsuit claims that Varonis misrepresented its revenue projections and growth potential while downplaying risks associated with seasonality and macroeconomic factors [3]. - It is alleged that Varonis' optimistic reports regarding growth and sales effectiveness were not reflective of the company's actual performance [3]. - Following the release of third-quarter results on October 28, 2025, which fell short of expectations, Varonis lowered its full-year guidance, resulting in a nearly 49% drop in stock price [4]. Group 3: Legal Process and Firm Background - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Varonis stock during the class period to seek lead plaintiff status [5]. - The lead plaintiff will represent the interests of all class members and can choose a law firm for litigation [5]. - Robbins Geller Rudman & Dowd LLP, the firm handling the case, is a leading class action firm with a strong track record in securities fraud litigation, having recovered over $916 million for investors in 2025 alone [6].

SAN DIEGO, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of CoreWeave, Inc. (NASDAQ: CRWV) securities between March 28, 2025 and December 15, 2025, inclusive (the “Class Period”), have until Friday, March 13, 2026 to seek appointment as lead plaintiff of the CoreWeave class action lawsuit. Captioned Masaitis v. CoreWeave, Inc., No. 26-cv-00355 (D.N.J.), the CoreWeave class action lawsuit charges CoreWeave as well as certain of CoreWeave’s top execu ...

Core Viewpoint - Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Ocular Therapeutix, Inc. regarding possible recovery of investor losses under federal securities laws following a significant stock price decline after trial results announcement [1][4]. Group 1: Investigation Details - The investigation focuses on Ocular's executive officers and their compliance with federal securities laws [1][4]. - Ocular announced topline results from its SOL-1 Phase 3 trial on February 17, 2026, revealing that 74% of patients maintained vision at nine months, 66% at twelve months, and approximately 69% were rescue-free at 52 weeks [3]. - Following the announcement, Ocular's stock price declined approximately 27% [3]. Group 2: Law Firm Background - Johnson Fistel, PLLP is a nationally recognized shareholder-rights law firm with multiple offices across the United States, representing both individual and institutional investors [5]. - The firm has been ranked among the Top 10 Plaintiff Law Firms by ISS Securities Class Action Services in 2024, having recovered approximately $90.725 million for clients in cases where it served as lead or co-lead counsel [6].

Core Viewpoint - Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Helen of Troy Limited regarding possible recoveries of investor losses under federal securities laws [1]. Group 1: Investigation Details - The investigation focuses on whether Helen of Troy's executive officers complied with federal securities laws following significant financial disclosures [1][3]. - On October 9, 2025, Helen of Troy reported $326.4 million in pre-tax asset impairment charges for the quarter ended August 31, 2025, leading to a stock price decline of approximately 25% [3]. Group 2: Investor Participation - Investors who purchased Helen of Troy securities and suffered losses are encouraged to join the investigation, with no cost or obligation [2]. Group 3: Firm Background - Johnson Fistel, PLLP is a nationally recognized law firm specializing in shareholder rights, with multiple offices across the United States [4]. - The firm has been ranked among the Top 10 Plaintiff Law Firms in 2024, recovering approximately $90.7 million for clients in securities cases [5].

Core Viewpoint - Picard Medical, Inc. (PMI) shareholders who incurred losses have the opportunity to lead a securities fraud class action lawsuit due to alleged undisclosed fraudulent activities by the company [1] Summary by Relevant Sections Lawsuit Details - The lawsuit alleges that between September 2, 2025, and October 31, 2025, Picard Medical failed to disclose critical information to investors, including involvement in a fraudulent stock promotion scheme utilizing social media misinformation and impersonation of financial professionals [1] - It is claimed that insiders or affiliates used offshore or nominee accounts to facilitate coordinated share dumping during a price inflation campaign [1] - The company's public statements and risk disclosures reportedly omitted any mention of false rumors and artificial trading activity that influenced the stock price [1] - As a result, the positive statements made by the defendants regarding the company's business, operations, and prospects were materially misleading and lacked a reasonable basis [1]

NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Ostin Technology Group Co., Ltd. (NASDAQ: OST) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Ostin securities between May 11, 2025 and June 26, 2025, bo ...

Richtech Robotics Inc. (RR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit [Accessibility Statement] Skip NavigationLOS ANGELES, Feb. 18, 2026 /PRNewswire/ -- [The Law Offices of Frank R. Cruz] announces that investors with losses related to Richtech Robotics Inc. ("Richtech" or the "Company") (NASDAQ: [RR]) have opportunity to lead the securities fraud class action lawsuit.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN RICHTECH ROBOTICS INC. (RR), CLICK [HERE] BEFORE APRIL 3, ...

Oracle Corporation (ORCL) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit [Accessibility Statement] Skip NavigationLOS ANGELES, Feb. 18, 2026 /PRNewswire/ -- [The Law Offices of Frank R. Cruz] announces that investors with losses related to Oracle Corporation ("Oracle" or the "Company") (NYSE: [ORCL]) have opportunity to lead the securities fraud class action lawsuit.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ORACLE CORPORATION (ORCL), CLICK [HERE] BEFORE APRIL 6, 2026 (THE ...

Philadelphia, Pennsylvania--(Newsfile Corp. - February 18, 2026) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) ("Ultragenyx" or the "Company") on behalf of investors who purchased Ultragenyx common stock during the period from August 3, 2023 through December 26, 2025 (the "Class Period").Investor Deadline: Investors who purchased Ultragenyx common stock during the Class Period may, no later than ...

Levi & Korsinsky Reminds Paysafe Limited Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2026 - PSFE [Accessibility Statement] Skip NavigationNEW YORK, Feb. 18, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Paysafe Limited ("Paysafe Limited" or the "Company") (NYSE: PSFE) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Paysafe Limited investors who were adversely affected by alleged securities ...